PRLB Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 1.97%, SMA50 11.16%, SMA200 29.37%). The stock’s 14-day RSI is 57.54 (neutral), while the ATR of 2.32 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -8.62% below its high and over 112.84% above its low. Average 10-day trading volume of 219.66 thousand shares is in line with the 3-month average of 211.39 thousand, indicating normal recent market interest.

Proto Labs, Inc. generated EPS of $0.88 over the past year. Five-year average earnings growth is -14.26%. The latest quarter delivered EPS of $0.60. The next quarter is forecast at $0.40. Next year's EPS is expected at $6.35. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 3 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $91.00 to $55.00. The high target offers 3.7% upside. The low target suggests -37.32% downside. The mean target is $77.67. This offers -11.49% upside. Proto Labs, Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended July 31, 2026, missed forecasts by 13.21%. The prior quarter beat by 35.0%. Over the last six quarters, Apple has recorded several small beats. These include 17.86% in May 02, 2025.

Proto Labs, Inc. has 23.79 million shares outstanding. The public float is 23.48 million shares, elevated short interest at 3.91% of float. This equals 676.42 thousand shares. The short ratio is 2.49 days. Institutional investors hold 95.42% of the float. Insiders own 1.31%. LUKIS LAWRENCE J holds 2.08 million shares, Bodor Robert has 80.88 thousand shares and HOLT VICTORIA M has 58.46 thousand shares. Over the past six months, insider transactions show net selling. They sold 14.78 thousand shares across 4 transactions.

Proto Labs, Inc. (NYSE:PRLB) closed at $87.75 USD, gaining $1.33 (1.54%) from the previous close of $86.42. The stock is currently mid-range between its 52-week high and low $45.10 and $93.00. With a market capitalization of about $2.09 billion, Proto Labs, Inc. is classified as a mid-cap and shows higher-than-market volatility (beta ~1.42). Key stats such as the average daily volume over the past year has been around 207.21 thousand shares, trading with heavier-than-usual volume. Headquartered in Maple Plain, MN, Proto Labs, Inc. operates in the Industrials sector and the Manufacturing - Miscellaneous industry. Led by CEO Suresh Krishna, the company employs approximately 2,280 people and listed since February 24, 2012. Proto Labs, Inc., together with its affiliated companies, functions as a global, e-commerce-driven digital manufacturer, specializing in the rapid creation of custom prototypes and on-demand production components.

Proto Labs, Inc. trades at a P/E ratio of 68.35, slightly above the S&P 500 average, with a price-to-sales ratio of 3.68 and a price-to-book ratio of 3.0 trading at moderately above to book value. The P/FCF stands at 33.32, also above market averages.

Proto Labs, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $26.71. This means the shares are trading above this model’s fair value.

Our AI price prediction model suggests that Proto Labs, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -6.89%, with price expected at $81.70 by October 01, 2026, within a range of $75.60 to $87.44 3-Month Outlook: Projected fall of -14.44%, reaching $75.08 by December 16, 2026, with a range of $72.82 to $77.19. 1-Year Outlook: Projected gain of 16.15%, with price at $101.92 by September 17, 2027, within a range of $98.37 to $104.97.

Proto Labs, Inc. (NYSE:PRLB) shares are flat 4.82% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Proto Labs, Inc. trading at a premium to the broader market with a P/E of 68.35. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $74.46, suggesting -15.15% downside. Our AI forecast model points to short-term weakness (-6.89% over two weeks), a medium-term fall (-14.44% over three months), and a longer-term gain (16.15% over one year), with expected trading ranges indicating moderate volatility.